What one share of Bullfrog Ai Holdings holds
III oncology company focused on novel chemotherapeutic treatments for rare cancers. Through this collaboration, we will apply our proprietary
Bullfrog Ai Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.02 |
|---|---|
| Profit | −$0.45 |
| Cash and investments | $0.37 |
| Book value | $0.38 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2021 | — | −$0.14 | — | — | — | −$0.22 |
| 2022 | $0.00 | −$0.70 | $0.00 | −$0.23 | — | −$0.76 |
| 2023 | $0.01 | −$0.89 | — | — | — | $0.43 |
| 2024 | — | −$0.85 | — | — | — | $0.54 |
| 2025 | $0.01 | −$0.63 | — | — | — | $0.19 |
Common questions about Bullfrog Ai Holdings
How much does one share of Bullfrog Ai Holdings earn?
Over the last 12 months, Bullfrog Ai Holdings lost $0.45 for each share on $0.02 of sales.
Does Bullfrog Ai Holdings pay a dividend?
Bullfrog Ai Holdings didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Bullfrog Ai Holdings’s book value per share?
Bullfrog Ai Holdings’s book value is $0.38 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Bullfrog Ai Holdings have?
Each share of Bullfrog Ai Holdings has $0.37 of cash and investments, as of June 30, 2026.
Has Bullfrog Ai Holdings bought back shares?
Bullfrog Ai Holdings’s share count rose about 151% from 2021 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.